CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
1.090
+0.050 (4.81%)
At close: Apr 25, 2025, 4:00 PM
1.120
+0.030 (2.75%)
After-hours: Apr 25, 2025, 6:54 PM EDT
CNS Pharmaceuticals Employees
As of December 31, 2024, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,971,560
Market Cap
3.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CNSP News
- 25 days ago - CNS Pharmaceuticals Reports Full Year 2024 Financial Results - Accesswire
- 4 weeks ago - CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects - Benzinga
- 4 weeks ago - CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Accesswire
- 2 months ago - CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing - Accesswire
- 2 months ago - CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum - Accesswire
- 2 months ago - CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Accesswire
- 2 months ago - CNS Pharmaceuticals Announces Reverse Stock Split - Accesswire
- 2 months ago - CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit - Accesswire